A Study on the Safety and Tolerability of Universal STAR-T Cell Therapy for Multiple Sclerosis.
A Study on the Safety and Tolerability of Universal STAR-T Cell Therapy for Multiple Sclerosis.
Not yet recruiting · NCT07523100 · Registry updated 2026-04-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study on the Safety and Tolerability of Universal STAR-T Cell Therapy for Multiple Sclerosis. | CNS demyelinating autoimmune disease, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder | Not yet recruiting | Phase 1 | 2026-04-13 | NCT07523100 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| China Immunotech (Beijing) Biotechnology Co., Ltd. | 14 |
| Daishi Tian | 6 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science & Technology | Wuhan | China | 12 |